Are you above the legal age to view this content in your province/state?

Home / Tag Archives: FSDPharma (page 5)

Tag Archives: FSDPharma

FSD PHARMA looking at acquisitions as it continues its build out of facility in Ontario

FSD Pharma Inc. (OTCQB:FSDDF)(CSE:HUGE) Interim CEO Raza Bokhari sat down with Christine Corrado from Proactive Investors New York at the 11th Annual Biotech Showcase in San Francisco. The Canadian cannabis company, through its wholly-owned subsidiary FV Pharma Inc., holds an ACMPR license to cultivate cannabis under the Access to Cannabis …

Read More »

Interview with Dr Raza Bokhari about FSD Pharma

Dr Raza Bokhari, Executive Co-Chairman & Interim CEO CSE:HUGE, OTC:FSDDF, FRA:0K9 FSD has 25,000 square feet available for production at its Ontario facility with an additional 220,000 square feet currently in development. FSD’s R&D platform is focused on cannabinoids and their potential for widespread clinical applications. FSD has a strong …

Read More »

FSD Pharma makes acquisition and receives Cannabis sales license from Health Canada

FSD Pharma (CSE:HUGE-OTCQB:FSDDF) Executive Co-Chairman and CEO Dr Raza Bokhari sat down with Steve Darling from Proactive Investors Vancouver to talk about FSD hitting a company milestone by receiving their cannabis sales license from Health Canada. Dr Bokhari also told Proactive about their recent acquisition of Prismic Pharmaceuticals. That company …

Read More »

Insight into the Canadian cannabis industry. FSD holds a lot of promise

Insight into the Canadian cannabis industry

The bloom in the Canadian cannabis industry is fast gaining momentum. In the countdown to October 17th 2018, several Canadian cannabis companies are seeking to bolster their investment, take a firm hold of sizable customer base and make the most of the early bird gains. The Canadian cannabis industry has …

Read More »

FSD Pharma Acquires Therapix Biosciences Ltd.

FSD Pharma Acquires Therapix Biosciences Ltd.

Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of Senior Executives and Scientists. FSD Pharma Inc. (“FSD Pharma” or the “Company”) (OTCPK:FSDDF) (HUGE:CN) (HUGE:CNX) announced the signing of a binding letter of intent (the “LOI”) to acquire Therapix Biosciences Ltd. (“Therapix Biosciences” or “Therapix”) (NASDAQ: …

Read More »

Niagara college Initiates Cannabis production program

Niagara college Initiates Cannabis production program

The bloom of movement in the cannabis industry is reaching the academia. Recent reports point to the fact that the industry is taking a definite shape and is exercising its bragging rights. Investors’ confidence like those of the academia is blossoming, and it is this regards that we are pleased …

Read More »

7 Amazing facts about cannabis you didn’t know-FSD

7 Amazing facts about cannabis you didn't know

With the current momentum surrounding the use of the cannabis plant, there is a great deal of information that continues to pour out onto internet about the plant. There are some amazing facts but even more misconceptions. To kill the lies and expose the truth, we thought to bring to …

Read More »

Disclaimer

Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.


Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.


DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.


Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.


Investment Value Finders is intended for those 21+ years of age only!